Possible Transfusion-Transmitted Babesia divergens-like/MO-1 Infection in an Arkansas Patient.
A patient with asplenia and multiple red blood cell transfusions acquired babesiosis infection with Babesia divergens-like/MO-1 organisms and not Babesia microti, the common United States species. He had no known tick exposure. This is believed to be the first transfusion-transmitted case and the fifth documented case of B. divergens-like/MO-1 infection.
Division of Infectious Diseases.
Mary J
MJ
Burgess
Departments of Pathology and.
Eric R
ER
Rosenbaum
Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota.
Bobbi S
BS
Pritt
Arkansas Department of Health, Little Rock.
Dirk T
DT
Haselow
Division of Infectious Diseases.
Katie M
KM
Ferren
Internal Medicine Residency Program, University of Arkansas for Medical Sciences, and.
Bashar N
BN
Alzghoul
Division of Infectious Diseases.
Juan Carlos
JC
Rico
Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota.
Lynne M
LM
Sloan
Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota.
Poornima
P
Ramanan
Internal Medicine Residency Program, University of Arkansas for Medical Sciences, and.
Raghunandan
R
Purushothaman
Division of Infectious Diseases.
Robert W
RW
Bradsher
D000369:Aged, 80 and over; D001131:Arkansas; D001403:Babesia / Q000302:isolation & purification; D001404:Babesiosis / Q000188:drug therapy / Q000469:parasitology / Q000635:transmission*; D001803:Blood Transfusion; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D017713:Platelet Transfusion; D011803:Quinine / Q000008:administration & dosage / Q000627:therapeutic use; D014481:United States
D002981:Clindamycin; D011803:Quinine; D004318:Doxycycline
Babesia divergens–like; babesiosis; transfusion-transmitted infection.